Načítá se...

IMMU-22. PHARMACOLOGICALLY TARGETING EXTRACELLULAR VESICLE-IMMUNE CELL INTERACTIONS IN GLIOBLASTOMA

Glioblastoma (GBM) is the most aggressive type of primary brain cancer and carries a dire prognosis. Increasing evidence points to extracellular vesicles (EVs) as a means by which GBM tumor cells modulate the tumor microenvironment, leading to immunosuppression and disease progression. Several pharm...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Himes, Benjamin, Fain, Cori, Tritz, Zachariah, Parney, Ian
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217289/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.525
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!